Three ETFs—two buys and one we don’t like

Here’s a look at three popular ETFs in three different areas—medical-device makers, natural resource producers and S&P 500 companies (but with a twist). We like the first two, but we think the third is likely to underperform its “plain vanilla” counterpart.
Meanwhile, the Supplement on page… Read More

Here’s your look at three more ETFs for 2021

Vaccination plans in the U.S. and globally have spurred a more positive economic outlook for 2021. Still, there are risks on the horizon, like potential delays in the rollout of those vaccines as well as political and trade-war tensions.
Here’s a look at three popular ETFs… Read More

Where ETF money is flowing right now

In Canada, stock market ETFs continue to attract new money—almost $20 billion flowed into these products this year through to the end of October. Most of that money went to funds focused on international markets, excluding Canada and the U.S.
Fixed-income ETFs also attracted strong inflows… Read More